Cargando…
Ligand-Based Drug Design of Novel Antimicrobials against Staphylococcus aureus by Targeting Bacterial Transcription
Staphylococcus aureus is a common human commensal pathogen that causes a wide range of infectious diseases. Due to the generation of antimicrobial resistance, the pathogen becomes resistant to more and more antibiotics, resulting in methicillin-resistant S. aureus (MRSA) and even multidrug-resistant...
Autores principales: | Ye, Jiqing, Yang, Xiao, Ma, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820117/ https://www.ncbi.nlm.nih.gov/pubmed/36613782 http://dx.doi.org/10.3390/ijms24010339 |
Ejemplares similares
-
Nusbiarylins Inhibit Transcription and Target Virulence Factors in Bacterial Pathogen Staphylococcus aureus
por: Chu, Adrian Jun, et al.
Publicado: (2020) -
Antimicrobial Activity of Clinically Isolated Bacterial Species Against Staphylococcus aureus
por: Hardy, Britney L., et al.
Publicado: (2020) -
QSAR, Docking, and Molecular Dynamics Simulation Studies of Sigmacidins as Antimicrobials against Streptococci
por: Ye, Jiqing, et al.
Publicado: (2022) -
Comparison of the In vitro Activity of Five Antimicrobial Drugs against Staphylococcus pseudintermedius and Staphylococcus aureus Biofilms
por: Ferran, Aude A., et al.
Publicado: (2016) -
Repurposing Selamectin as an Antimicrobial Drug against Hospital-Acquired Staphylococcus aureus Infections
por: Folliero, Veronica, et al.
Publicado: (2023)